The healthcare industry is undergoing a transformative era, with artificial intelligence (AI) and digital health solutions reshaping patient care and hospital resilience worldwide. At the forefront of this innovation is Amoul®, a global leader in life support and critical care technology. During the 38th Indonesia International Hospital Expo 2026—Southeast Asia's premier event for healthcare advancement—Amoul® showcased our cutting-edge portfolio of AI-powered medical devices, capturing the attention of clinicians, hospital administrators, and healthcare technology experts alike.

The 38th Indonesia International Hospital Expo: A Hub for Healthcare Innovation

Concluding on October 7, 2026, the Indonesia International Hospital Expo took place at the renowned Indonesia Convention Exhibition (ICE) BSD City in Tangerang, Greater Jakarta. Organized by PT Okta Sejahtera Insani, this four-day event drew more than 600 domestic and international companies, making it Southeast Asia's longest-running and most influential healthcare trade show. Themed "Hospitals Growing and Resilient in the Era of Artificial Intelligence," the expo spotlighted the latest advances in AI-driven medical technology and digital health innovation.

Amoul® took center stage, joining other major players in demonstrating how artificial intelligence is revolutionizing hospital resilience, boosting operational efficiency, and elevating patient outcomes. As hospitals worldwide grapple with unprecedented challenges—from pandemic preparedness to increasing patient loads—AI-integrated solutions are proving indispensable for the future of critical care.

Amoul®: Pioneering Life Support Technology

Since its inception, Amoul® has been dedicated to saving lives and improving clinical outcomes through relentless research and development in emergency and intensive care medicine. The company's mission is simple yet powerful: to empower clinicians with intelligent, high-performance medical devices that address the most pressing needs in critical care environments.

At the Indonesia International Hospital Expo 2026, Amoul® proudly presented its next-generation portfolio, including advanced ventilators for ICU and emergency transport, CPAP machines, G1 and G3 auto CPR devices, and innovative defibrillators and infusion pumps. These products are engineered with both patient comfort and clinician usability in mind, ensuring seamless integration into diverse healthcare settings.

Showcasing Advanced Ventilators and Emergency Devices

One of the main highlights at the Amoul® booth was the advanced range of transport and therapy ventilators, including the VK600, T6, T500, VT200, and the CPAP Anim25s. Designed for robust performance and precision, these ventilators offer versatile, user-friendly solutions for patients of all ages and acuity levels. Their adaptability allows for smooth transitions from pre-hospital ambulance care to intensive care units, making them essential tools for hospitals, emergency responders, transport rescue teams, home healthcare providers, and field medics.

The new generation of Amoul® ventilators puts patient safety and operational efficiency at the forefront. Features such as intelligent monitoring, real-time data analytics, and AI-assisted ventilation modes help clinicians make evidence-based decisions, optimizing care for critically ill patients. Whether used in high-pressure emergency situations or routine ICU management, these devices are built to deliver reliable, lifesaving support.

Educational Sessions and Live Demonstrations: Bridging the Knowledge Gap

Beyond cutting-edge technology, Amoul® is committed to advancing clinical practice through education. During the Hospital Expo, Amoul® hosted a series of educational sessions and live product demonstrations, providing healthcare professionals with hands-on experience and insights into the latest trends, regulatory updates, and best practices in emergency and critical care.

The interactive demonstrations allowed visitors to explore the full capabilities of Amoul®'s ventilators, resuscitation devices, and monitoring systems. By fostering an environment of learning and collaboration, Amoul® is empowering clinicians to stay at the forefront of medical innovation and deliver superior patient outcomes.

Driving the Future of Critical Care with AI and Digital Health

The presence of AI-driven medical devices at the Indonesia International Hospital Expo 2026 underscores a pivotal shift in how hospitals approach resilience and patient care. Amoul®'s portfolio is a testament to the power of integrating artificial intelligence and digital health solutions into daily clinical workflows. These innovations not only improve patient monitoring and therapeutic interventions but also reduce the cognitive burden on clinicians, enabling faster, data-driven decisions.

By investing in advanced life support technologies and ongoing clinician education, Amoul® is setting new benchmarks for critical care excellence in Indonesia and beyond. The company's unwavering focus on research, development, and practical application ensures that hospitals and healthcare providers are equipped to meet current and future challenges head-on.

Amoul®'s impactful presence at the 38th Indonesia International Hospital Expo 2026 highlights our leadership in the fast-evolving world of AI-powered medical devices and digital health. From pioneering ventilators and resuscitation systems to fostering clinical education, Amoul® is paving the way for resilient, future-ready hospitals. As healthcare systems strive to enhance patient outcomes and adapt to the demands of a rapidly changing landscape, Amoul® remains a trusted partner—delivering intelligent solutions that save lives and shape the future of critical care.